In person
One of our ADS scientists, Welmoet de Winter will represent our team at the upcoming ELRIG Conference, where she will present the research of our team on site-selective screening and fragment-based drug discovery.
Her poster: “Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14” focuses on the design and application of stable S-adenosylmethionine-based probes to support site-selective fragment screening against METTL3/14.
We look forward to seeing our research represented at the conference and to engaging with colleagues from the drug discovery community.
Good luck, Welmoet!